AI Article Synopsis

Article Abstract

The current study evaluated the impact of a whole-foods, plant-based nutrition intervention on metabolic markers of patients with chronic disease in an underserved community setting. A retrospective analysis of metabolic biomarkers preintervention and postintervention was conducted on 31 patients with metabolic disease who attended an Eating for Life group visit series. Significant decreases were found for body mass index (BMI; -0.66 [-0.91 to -0.40] kg/m), systolic blood pressure (-12 [-19 to -5] mm Hg), total cholesterol (-20 [-29 to -10] mg/dL), low-density lipoprotein (LDL; -11.6 [-17.5 to -5.5] mg/dL), and high-density lipoprotein (HDL; -3.2 [-5.7 to -0.7] mg/dL, all Ps < .01). In participants with clinically abnormal preintervention data, the mean (95% CI) change significantly decreased for overweight (-0.45 [-0.85 to -0.05]) and obese (-0.76 [-1.13 to -0.39]) BMI, systolic blood pressure (-12 [-19 to -5] mm Hg), total cholesterol -22 [-40 to -4] mg/dL), and LDL (-15.6 [-23.8 to -7.4] mg/dL, all Ps ≤ .03). In conclusion, the Eating for Life model showed significant improvement in BMI, diastolic blood pressure, total cholesterol, and LDL in a federally qualified health center population. Group visits advocating for a whole-foods, plant-based diet may be effective in reducing chronic disease burden in underserved communities.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9189580PMC
http://dx.doi.org/10.1177/15598276211018159DOI Listing

Publication Analysis

Top Keywords

whole-foods plant-based
12
chronic disease
12
blood pressure
12
total cholesterol
12
impact whole-foods
8
plant-based nutrition
8
nutrition intervention
8
disease underserved
8
underserved community
8
eating life
8

Similar Publications

Breast cancer (BC) is one of the leading causes of death and morbidity among women worldwide. Epidemiologic evidence shows that the risk of BC and other chronic diseases decreases as the proportion of whole plant foods increases, while the proportion of animal foods (fish, meat, poultry, eggs, seafood, and dairy products) and non-whole plant foods (e.g.

View Article and Find Full Text PDF

Military Veterans have a higher risk of incident atherosclerotic cardiovascular disease (ASCVD) than the general population and are often clinically complex. We studied the changes in cardiovascular risk factors with a lifestyle intervention in this population. We retrospectively analyzed data from 67 participants (mean age 69.

View Article and Find Full Text PDF

The Role of Whole Food Plant-Based Food Intake on Postprandial Glycemia in Type 1 Diabetes.

J Clin Endocrinol Metab

October 2024

Division of Pediatric Endocrinology, Department of Pediatrics, Stanford University, Stanford, CA, USA.

Background: Whole food plant-based diet (WFPBD), minimally processed foods with limited consumption of animal products, is associated with improved health outcomes. The benefits of WFPBD are underexplored in individuals with type 1 diabetes (T1D). The primary objective of this analysis is to evaluate the association between WFPBD on glycemia in individuals with T1D.

View Article and Find Full Text PDF

Excess body adiposity, referred to as overweight and obesity, represents a major health concern given that it increases the risk of various diseases, including cardiovascular diseases, type 2 diabetes, and cancer. Body weight reduction can be achieved via a wide variety of dietary strategies as long as an energy deficit is achieved. However, the effect of such diets on disease risk and mortality will depend on the foods included.

View Article and Find Full Text PDF

Exploring Diet-Based Treatments for Atrial Fibrillation: Patient Empowerment and Citizen Science as a Model for Quality-of-Life-Centered Solutions.

Nutrients

August 2024

Department of Physiology, Amsterdam UMC, Location Vrije Universiteit, Amsterdam Cardiovascular Sciences, Heart Failure and Arrhythmias, 1081 HZ Amsterdam, The Netherlands.

Atrial fibrillation (AF) is the most common heart rhythm disorder in the Western world. Between the years 2010 and 2019, the global prevalence of AF rose from 33.5 million to 59 million, highlighting the importance of developing equitable treatments for patients.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!